- Home
- ELSE vs NLSP Comparison
ELSE vs NLSP Comparison
Compare ELSE & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- NLSP
- Stock Information
- Founded
- ELSE 1968
- NLSP 2015
- Country
- ELSE United States
- NLSP Switzerland
- Employees
- ELSE N/A
- NLSP N/A
- Industry
- ELSE Industrial Machinery/Components
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- ELSE Industrials
- NLSP Health Care
- Exchange
- ELSE Nasdaq
- NLSP Nasdaq
- Market Cap
- ELSE 14.7M
- NLSP 12.4M
- IPO Year
- ELSE N/A
- NLSP 2021
- Fundamental
- Price
- ELSE $4.25
- NLSP $2.33
- Analyst Decision
- ELSE
- NLSP
- Analyst Count
- ELSE 0
- NLSP 0
- Target Price
- ELSE N/A
- NLSP N/A
- AVG Volume (30 Days)
- ELSE 11.2K
- NLSP 328.3K
- Earning Date
- ELSE 08-08-2025
- NLSP 07-01-2025
- Dividend Yield
- ELSE N/A
- NLSP N/A
- EPS Growth
- ELSE 14.32
- NLSP N/A
- EPS
- ELSE 0.11
- NLSP N/A
- Revenue
- ELSE $9,368,000.00
- NLSP N/A
- Revenue This Year
- ELSE N/A
- NLSP N/A
- Revenue Next Year
- ELSE N/A
- NLSP N/A
- P/E Ratio
- ELSE $39.14
- NLSP N/A
- Revenue Growth
- ELSE 7.01
- NLSP N/A
- 52 Week Low
- ELSE $3.65
- NLSP $1.30
- 52 Week High
- ELSE $5.50
- NLSP $16.00
- Technical
- Relative Strength Index (RSI)
- ELSE 52.47
- NLSP 56.71
- Support Level
- ELSE $4.15
- NLSP $2.22
- Resistance Level
- ELSE $4.40
- NLSP $2.54
- Average True Range (ATR)
- ELSE 0.18
- NLSP 0.20
- MACD
- ELSE -0.00
- NLSP -0.02
- Stochastic Oscillator
- ELSE 55.81
- NLSP 44.79
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.